Skip to main content
Livermore
Livermore
ZHEN

Great Diamond Partners, LLC

SEC CIK
0001801112
Latest filing
Jul 17, 2026

REGN holding history

Regeneron Pharmaceuticals, Inc. in every 13F filed by Great Diamond Partners, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

REGN overviewAll 13F holders of REGNFull Q2 2026 holdings

Shares (Q2 2026)
431
Value
$268.7K
% of portfolio
<0.1%
Quarters held
22
Since Q1 2021
Holdings of REGN by Great Diamond Partners, LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 2026431$268.7K<0.1%−53−11.0%ReducedHolders
Q1 2026484$374.0K0.1%−10−2.0%ReducedHolders
Q4 2025494$381.3K0.1%−33−6.3%ReducedHolders
Q3 2025527$296.3K0.1%−8−1.5%ReducedHolders
Q2 2025535$280.9K0.1%+108+25.3%AddedHolders
Q1 2025427$270.8K0.1%+98+29.8%AddedHolders
Q4 2024329$234.4K0.1%−6−1.8%ReducedHolders
Q3 2024335$352.2K0.1%−254−43.1%ReducedHolders
Q2 2024589$619.1K0.1%−10−1.7%ReducedHolders
Q1 2024599$576.5K0.1%−8−1.3%ReducedHolders
Q4 2023607$533.1K0.1%−17−2.7%ReducedHolders
Q3 2023624$513.5K0.1%+1+0.2%AddedHolders
Q2 2023623$447.6K0.1%+26+4.4%AddedHolders
Q1 2023597$490.5K0.1%+4+0.7%AddedHolders
Q4 2022593$427.8K0.1%−129−17.9%ReducedHolders
Q3 2022722$497.0K0.2%+1+0.1%AddedHolders
Q2 2022721$426.0K0.1%−196−21.4%ReducedHolders
Q1 2022917$640.0K0.2%−53−5.5%ReducedHolders
Q4 2021970$612.0K0.2%+1+0.1%AddedHolders
Q3 2021969$586.0K0.2%−2−0.2%ReducedHolders
Q2 2021971$542.0K0.2%00.0%UnchangedHolders
Q1 2021971$459.0K0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.